32 results
6-K
EX-99.1
IPA
ImmunoPrecise Antibodies Ltd
27 Nov 23
Immunoprecise Antibodies LTD. 6-K
8:31am
underscores IPA's commitment to maintaining the highest standards of financial oversight and corporate governance.
"We at IPA are thrilled to embark … , and corporate governance, especially in Nasdaq-listed environments, not only reflects the strong backing we have from our shareholders but also
6-K
EX-99.1
IPA
ImmunoPrecise Antibodies Ltd
20 Oct 23
Current report (foreign)
2:56pm
and pharma.
- 24 -
CORPORATE GOVERNANCE DISCLOSURE
National Instrument 58-101 - Disclosure of Corporate Governance Practices, requires all reporting … issuers to provide certain annual disclosure of their corporate governance practices with respect to the corporate governance guidelines (the "Guidelines
6-K
EX-99.1
IPA
ImmunoPrecise Antibodies Ltd
9 Aug 23
Immunoprecise Antibodies LTD. 6-K
9:15am
to upholding high standards in corporate governance. Under the Majority Voting Policy, any director who receives more "withheld" votes than "for" votes
40-F
2023 FY
IPA
ImmunoPrecise Antibodies Ltd
10 Jul 23
Annual report (Canada)
4:32pm
corporate governance standards. In order to claim such exemption, the Company must disclose the NASDAQ corporate governance standards that it does … not follow and describe the home country practice that it follows in lieu of such standards. The disclosure of corporate governance differences may
40-F
2023 FY
EX-99.1
IPA
ImmunoPrecise Antibodies Ltd
10 Jul 23
Annual report (Canada)
4:32pm
domestic companies. In addition, as a foreign private issuer, the Company has the option to follow certain Canadian corporate governance practices … domestic companies that are subject to all United States corporate governance requirements.
Loss of Foreign Private Issuer Status
The Company may
6-K
EX-99.2
r8t8hag
17 Nov 22
Current report (foreign)
9:36am
40-F
3x8e oe40j9v7byonbsn
29 Jul 22
Annual report (Canada)
9:04am
40-F
EX-99.1
z4qtwdks8mu53y
29 Jul 22
Annual report (Canada)
9:04am
6-K
EX-99.1
6aq3l3hyr3552
12 Nov 21
Current report (foreign)
8:58am
SUPPL
347p1
13 Oct 21
Supplemental materials (foreign)
5:29pm
40-F
jgaqoy jk
28 Jul 21
Annual report (Canada)
8:01am
40-F
EX-99.1
r65ea7ppkjogda
28 Jul 21
Annual report (Canada)
8:01am
SUPPL
3f8y0
4 Feb 21
Supplemental materials (foreign)
5:08pm
SUPPL
1xkipu11j47pp
3 Feb 21
Supplemental materials (foreign)
4:42pm
F-10/A
EX-4.1
veuz24 19
5 Jan 21
Registration of securities (Canada) (amended)
5:29pm
F-10/A
ukj166f
5 Jan 21
Registration of securities (Canada) (amended)
5:29pm
40FR12B/A
jit6vj 4d4amu43cv5ev
28 Dec 20
Initial registration of securities (Canada) (amended)
4:02pm
40FR12B/A
ix5rcv5b1o5kfep3x mk
22 Dec 20
Initial registration of securities (Canada) (amended)
11:05am
40FR12B/A
EX-99.133
jtfvyyu z3h
22 Dec 20
Initial registration of securities (Canada) (amended)
11:05am
40FR12B/A
EX-99.135
2dpd613 f0
22 Dec 20
Initial registration of securities (Canada) (amended)
11:05am